(Ebook) Protocols for High-Risk Pregnancies : An Evidence-Based Approach by John T. Queenan (Editor), Catherine Y. Spong (Editor), Charles J. Lockwood (Editor) ISBN 9781119635260, 9781119635284, 9781119635291, 9781119635307, 1119635268, 1119635284, 1119635292, 1119635306, 2020024021

(Ebook) Protocols for High-Risk Pregnancies : An Evidence-Based Approach by John T. Queenan (Editor), Catherine Y. Spong (Editor), Charles J. Lockwood (Editor) ISBN 9781119635260, 9781119635284, 9781119635291, 9781119635307, 1119635268, 1119635284, 1119635292, 1119635306, 2020024021

The current acceleration in medical discoveries parallels Moore’s law forcomputer chips. In the 1950s, medical knowledge doubled every 50 years, bythe 1980s it doubled every seven years, and now medical knowledge isestimated to double about every two months (Densen 2011). How can busyobstetricians keep pace? Through seven editions, Protocols for High‐Risk Pregnancieshas helped address this exact challenge. Providing just‐in‐time content, its focuson protocols and guidelines helps organize medical thinking, avoid heuristicerrors of omission and commission, and optimize maternal and fetal outcomes.As with the prior six editions, we have once again assembled some of theworld’s top obstetrical and medical experts. Concomitantly, the seventhedition adds a number of new features including protocols on opioid use, misuseand addiction in pregnancy and postpartum, noninvasive prenatal diagnosisof aneuploidy, periconceptional genetic screening, and expanded protocolson maternal valvular heart disease and cardiomyopathies; we have also addedprotocols on arboviruses including Zika, and malaria, to reflect new technologies,changing clinical disease patterns, and emerging global pathogens.As in prior editions, our focus has been on conducting a comprehensivesurvey of recent relevant literature to extract the most current evidencebasedpractices and then presenting them with concise, focused text andcrystal‐clear clinical paradigms. In areas where there are reasonable clinicalalternatives, where no single compelling randomized clinical trial or a clearmetaanalytical preference is available, we have again asked the authors touse their best judgment to make recommendations.